Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Oluyemi S. Falegan"'
Autor:
Oluyemi S. Falegan, Shanna A. Arnold Egloff, Andries Zijlstra, M. Eric Hyndman, Hans J. Vogel
Publikováno v:
Metabolites, Vol 9, Iss 8, p 155 (2019)
Renal cell carcinoma (RCC) is a heterogeneous malignancy which often develops and progresses asymptomatically. Benign oncocytomas are morphologically similar to malignant chromophobe RCC and distinguishing between these two forms on cross-sectional i
Externí odkaz:
https://doaj.org/article/c23c2b46eb574c8dae6e78bf310d16de
Autor:
Oluyemi S. Falegan, Mark W. Ball, Rustem A. Shaykhutdinov, Phillip M. Pieroraio, Farshad Farshidfar, Hans J. Vogel, Mohamad E. Allaf, Matthew E. Hyndman
Publikováno v:
Metabolites, Vol 7, Iss 1, p 6 (2017)
Renal cell carcinoma (RCC) is a heterogeneous disease that is usually asymptomatic until late in the disease. There is an urgent need for RCC specific biomarkers that may be exploited clinically for diagnostic and prognostic purposes. Preoperative fa
Externí odkaz:
https://doaj.org/article/9f9b5369b8154327957e92083049c2d0
Autor:
Oluyemi S. Falegan, Dustin S. Hittel, Steven L. Britton, Hans J. Vogel, Lauren G. Koch, Russell T. Hepple, Jane Shearer
Publikováno v:
Journal of Proteome Research. 16:798-805
Advancing age is associated with declines in maximal oxygen consumption. Declines in aerobic capacity not only contribute to the aging process but also are an independent risk factor for morbidity, cardiovascular disease, and all-cause mortality. Alt
Publikováno v:
Metabolites, Vol 9, Iss 8, p 155 (2019)
Metabolites
Volume 9
Issue 8
Metabolites
Volume 9
Issue 8
Renal cell carcinoma (RCC) is a heterogeneous malignancy which often develops and progresses asymptomatically. Benign oncocytomas are morphologically similar to malignant chromophobe RCC and distinguishing between these two forms on cross-sectional i
Autor:
Rustem Shaykhutdinov, Hans J. Vogel, Phillip M Pieroraio, Matthew E. Hyndman, Mohamad E. Allaf, Mark W. Ball, Oluyemi S. Falegan, Farshad Farshidfar
Publikováno v:
Metabolites
Metabolites; Volume 7; Issue 1; Pages: 6
Metabolites, Vol 7, Iss 1, p 6 (2017)
Metabolites; Volume 7; Issue 1; Pages: 6
Metabolites, Vol 7, Iss 1, p 6 (2017)
Renal cell carcinoma (RCC) is a heterogeneous disease that is usually asymptomatic until late in the disease. There is an urgent need for RCC specific biomarkers that may be exploited clinically for diagnostic and prognostic purposes. Preoperative fa
Autor:
Steven L. Britton, Dustin S. Hittel, Jane Shearer, Lauren G. Koch, Oluyemi S. Falegan, Russell T. Hepple, Hans J. Vogel
Publikováno v:
The FASEB Journal. 28